scholarly article | Q13442814 |
P356 | DOI | 10.1002/IJC.29805 |
P698 | PubMed publication ID | 26270488 |
P50 | author | Peter Gibbs | Q51552633 |
Jayesh Desai | Q56580375 | ||
Matthew W Croxford | Q63982944 | ||
Hui-li Wong | Q85795055 | ||
Natalie Turner | Q85899528 | ||
Susie Bae | Q87871911 | ||
Jeanne Tie | Q89907190 | ||
Arnoud J Templeton | Q91787962 | ||
Mathuranthakan Sinnathamby | Q114401193 | ||
P2093 | author name string | Ian Jones | |
Michael Christie | |||
Ben Tran | |||
Sagarika Tripathy | |||
Te Whiti Rogers | |||
P2860 | cites work | Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer | Q24614511 |
Inflammation and cancer | Q24649640 | ||
Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis | Q27022482 | ||
Towards the introduction of the 'Immunoscore' in the classification of malignant tumours | Q27026489 | ||
Immunity, Inflammation, and Cancer | Q27861048 | ||
A systematic review and meta-analysis of the relationship between chromosome 18q genotype, DCC status and colorectal cancer prognosis | Q28269226 | ||
Current status of gene expression profiling to assist decision making in stage II colon cancer | Q33829763 | ||
Effector memory T cells, early metastasis, and survival in colorectal cancer | Q33992461 | ||
Metastasis-Associated Gene Expression Changes Predict Poor Outcomes in Patients with Dukes Stage B and C Colorectal Cancer | Q34062558 | ||
Chemoprevention of colorectal cancer: systematic review and economic evaluation | Q34123639 | ||
The prognostic influence of tumour-infiltrating lymphocytes in cancer: a systematic review with meta-analysis | Q34188723 | ||
Independent validation of a prognostic genomic signature (ColoPrint) for patients with stage II colon cancer | Q34321215 | ||
Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial | Q34607843 | ||
Neutrophil/lymphocyte ratio predicts chemotherapy outcomes in patients with advanced colorectal cancer. | Q34806672 | ||
Tumour infiltrating lymphocytes and apoptosis are independent features in colorectal cancer stratified according to microsatellite instability status | Q35565700 | ||
American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer | Q35806164 | ||
Microsatellite instability has a positive prognostic impact on stage II colorectal cancer after complete resection: results from a large, consecutive Norwegian series | Q36776983 | ||
Comparison of the prognostic value of longitudinal measurements of systemic inflammation in patients undergoing curative resection of colorectal cancer. | Q37003283 | ||
Validation of the 12-gene colon cancer recurrence score in NSABP C-07 as a predictor of recurrence in patients with stage II and III colon cancer treated with fluorouracil and leucovorin (FU/LV) and FU/LV plus oxaliplatin. | Q37411227 | ||
Cancer-related inflammation and treatment effectiveness | Q38256601 | ||
Prognosis of stage II and III colon cancer treated with adjuvant 5-fluorouracil or FOLFIRI in relation to microsatellite status: results of the PETACC-3 trial. | Q38421451 | ||
Blood neutrophil-to-lymphocyte ratio predicts survival in patients with colorectal liver metastases treated with systemic chemotherapy. | Q43686080 | ||
Comorbidity and performance indices as predictors of cancer-independent mortality but not of cancer-specific mortality after radical cystectomy for urothelial carcinoma of the bladder | Q44084230 | ||
A study of inflammation-based predictors of tumor response to neoadjuvant chemoradiotherapy for locally advanced rectal cancer | Q44980730 | ||
Tumor-infiltrating lymphocytes and perforation in colon cancer predict positive response to 5-fluorouracil chemotherapy | Q46721130 | ||
Histopathologic-based prognostic factors of colorectal cancers are associated with the state of the local immune reaction. | Q51023201 | ||
Validation study of a quantitative multigene reverse transcriptase-polymerase chain reaction assay for assessment of recurrence risk in patients with stage II colon cancer. | Q51502354 | ||
Cancer-specific and non-cancer-related mortality rates in European patients with T1a and T1b renal cell carcinoma. | Q51860276 | ||
Preoperative neutrophil to lymphocyte ratio >5 is a prognostic factor for recurrent colorectal cancer. | Q53362352 | ||
Gene Expression Signature to Improve Prognosis Prediction of Stage II and III Colorectal Cancer | Q56601042 | ||
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | systemic inflammation | Q7663815 |
colon cancer | Q18555025 | ||
P304 | page(s) | 671-678 | |
P577 | publication date | 2015-08-13 | |
P1433 | published in | International Journal of Cancer | Q332492 |
P1476 | title | Analysis of local chronic inflammatory cell infiltrate combined with systemic inflammation improves prognostication in stage II colon cancer independent of standard clinicopathologic criteria | |
P478 | volume | 138 |
Q33685545 | Assessment of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio and platelet count as predictors of long-term outcome after R0 resection for colorectal cancer |
Q92577787 | Clinical significance of tumor-infiltrating lymphocytes and neutrophil-to-lymphocyte ratio in patients with stage III colon cancer who underwent surgery followed by FOLFOX chemotherapy |
Q36821123 | Comparison of the prognostic value of measures of the tumor inflammatory cell infiltrate and tumor-associated stroma in patients with primary operable colorectal cancer |
Q94603190 | Development of a Novel Inflammation-Based Index for Hepatocellular Carcinoma |
Q38995724 | Examining the impact of regular aspirin use and PIK3CA mutations on survival in stage 2 colon cancer |
Q59354597 | Human leukocyte antigen gene polymorphisms are associated with systemic inflammation in hepatitis B virus-related hepatocellular carcinoma |
Q92510487 | Mismatch Repair Status of Gastric Cancer and Its Association with the Local and Systemic Immune Response |
Q33762053 | Neutrophil-to-lymphocyte ratio as prognostic indicator in gastrointestinal cancers: a systematic review and meta-analysis |
Q59794859 | Neutrophils to lymphocytes ratio as a useful prognosticator for stage II colorectal cancer patients |
Q64106610 | Novel Molecular Characterization of Colorectal Primary Tumors Based on miRNAs |
Q52884982 | Peripheral Neutrophil to Lymphocyte Ratio Improves Prognostication in Colon Cancer. |
Q64084593 | Prognostic Value of Preoperative Systemic Immune-Inflammation Index in Patients with Cervical Cancer |
Q57700802 | Prognostic impact of preoperative lymphocyte-to-monocyte ratio in patients with colorectal cancer with special reference to myeloid-derived suppressor cells |
Q59136283 | Prognostic value of inflammation-based scores in patients receiving radical resection for colorectal cancer |
Q91658773 | Relationship between local and systemic inflammatory response and prognosis in laryngeal squamous cell carcinoma |
Q92424731 | Single- versus two-port video-assisted thoracic surgery in mediastinal tumor: a propensity-matched study |
Q99726006 | Systemic Inflammatory Markers Are Predictive of the Response to Brachytherapy in the Prostate |
Q93184520 | Systemic inflammation in colorectal cancer: Underlying factors, effects, and prognostic significance |
Q37222061 | The association of clinical outcome and peripheral T-cell subsets in metastatic colorectal cancer patients receiving first-line FOLFIRI plus bevacizumab therapy |
Q37441444 | The prognostic value of systemic and local inflammation in patients with laryngeal squamous cell carcinoma |
Q47338550 | The role of the systemic inflammatory response in predicting outcomes in patients with operable cancer: Systematic review and meta-analysis. |
Q36338120 | Use of the combination of the preoperative platelet-to-lymphocyte ratio and tumor characteristics to predict peritoneal metastasis in patients with gastric cancer. |